Overlake First in Pacific Northwest to Treat Atrial Fibrillation With New FDA-Approved Pulsed Field Ablation
Overlake Medical Center & Clinics this week became the first hospital in the Pacific Northwest region to successfully treat patients for atrial fibrillation (AFib or...
Pima Heart & Vascular Hosts Leading Cardiology Conference in Tucson This February
Pima Heart & Vascular proudly announces its leadership role in hosting the CardioVascular Interventions Summit (CVIS) 2024, set for February 16-17 at the El Conquistador...
iCardio.ai Joins Butterfly Garden to Deploy Its Cardiac AI Suite on Butterfly Network’s Imaging Platform
iCardio.ai’s AI suite (pending FDA 510(k) clearance) includes instant automated interpretation of dozens of measurements of the heart, valvular disease detection, and image quality assessment....
CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services
The acquisition enhances patient care and extends CLS Health's geographical reach in the Houston area. CLS Health, formerly known as Clear Lake Specialties, has finalized...
Essex Cardiothoracic Centre Earns Award for Atrial Fibrillation Study That Demonstrates StatSeal Efficacy
Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats. The acclaimed...
Seigel Advisory Services Advises Shore Heart Group in a Partnership With Cardiovascular Associates of America
Seigel Advisory Services, a healthcare-focused investment bank, is pleased to announce that it has advised Shore Heart Group in a transaction with Cardiovascular Associates of...
VoluMetrix Awarded $3 Million NIH SBIR Phase IIb Grant to Propel Development of Non-Invasive Heart Failure Monitoring, NIVA|HF
VoluMetrix, a Nashville-based biotech startup dedicated to creating a new wave of solutions for vital monitoring to enhance well-being, announced today that it has been...
Biotricity’s Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
Dr. Waqaas will address, meet with, world leaders and medical innovators on pressing challenges and solutions in global cardiovascular health, digital health and AIREDWOOD CITY,...